Lexicon Pharmaceuticals, Inc. (LXRX) Given Consensus Recommendation...


Shares of Lexicon Pharmaceuticals, Inc. have earned an average rating of "Hold" from the eight brokerages that are covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and two have given a buy recommendation to the company.



from Biotech News